Christina Jenkins, MD

Fund(s): Active Aging & Longevity, FemTech Fund I & II
Location: New York

Christina Jenkins, MD (“CJ”) is a venture investor and board member who uses technology and trusted relationships to improve health, at scale.  Her expertise spans clinical medicine, health systems, and health plans, and she applies her unique perspective to enable value generation.

Dr. Jenkins is a Co-Founder and General Partner of Convergent Ventures, leading its health and life sciences investing strategy.  She focuses on Seed/A teams building AI-enabled platforms and products from drug discovery through to human diagnosis, therapy, and monitoring.  She is an investor board member of Biotia, Tensor Bio, and Noze.  

Dr. Jenkins is committed to advancing the health of women, formerly co-chairing an annual NYSE women’s health investor event and advising and investing for Portfolia’s women’s health focused funds.   

She is an independent board member of PE-backed companies Help at Home and Medical Solutions, and an advisory board member of Independence Health Group.   

Previously, Dr. Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals, the nation’s largest public hospital system.  There, she built a team from 0 to 130, leading a $1.2B effort to redesign the care delivery continuum, implement tech-enabled, services, and accelerate value-based payment readiness for 1M lives.

Dr. Jenkins earned her B.S. in Industrial Management at Purdue University and her M.D. from Northwestern University.  She’s a former board-certified Clinical Instructor of Medicine at Mount Sinai Medical Center in New York, where she also completed her residency.  CJ is a member of the Kauffman Fellows, a global leadership program in venture capital.